ACTIVATEUR DE NRF2 DESTINÉ AU TRAITEMENT D'UNE LÉSION PULMONAIRE AIGUË, DU SYNDROME DE DÉTRESSE RESPIRATOIRE AIGUË ET DU SYNDROME DE DYSFONCTIONNEMENT POLYVISCÉRAL
GlaxoSmithKline Intellectual Property Development Ltd
发明人:
申请号：
EP18836512.6
公开号：
EP3723764A1
申请日:
2018.12.11
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to the use of an NRF2 activator to treat respiratory diseases. In particular, the present invention relates to the treatment of respiratory diseases, in a mammal, in which related organ failure accompanied by accumulation of alveolar fluid, hypoxemia, cough, wheezing, dyspnea, hyperpnea and pulmonary inflammation has occurred.
